Advertisement

Topics

Cerulean Distributes Letter to Stockholders Requesting Favorable Vote for Proposals at July 19, 2017 Special Shareholder Meeting

08:30 EDT 19 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Cerulean Pharma Inc. (NASDAQ:CERU) today announced that the company mailed the following letter from President and Chief Executive Officer Christopher D. T. Guiffre to the company’s stockholders of record at the close of busin...

Other Sources for this Article

For Cerulean Pharma Inc.
Morrow Sodali, 203-658-9400
cerulean.info@morrowsodali.com

NEXT ARTICLE

More From BioPortfolio on "Cerulean Distributes Letter to Stockholders Requesting Favorable Vote for Proposals at July 19, 2017 Special Shareholder Meeting"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...